findmyKOL
Clinical trialNCT04347382CompletedPhase 3Interventional

Honey & Nigella Sativa Trial Against COVID-19

SponsorSohaib AshrafEnrollment313Coronavirus InfectionSars-CoV2
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Ayesha Hamayun, MBBS, PhD

    Shaikh Khalifa Bin Zayed Al-Nahyan Medical & Dental College, Lahore

    Principal Investigator
  • Muhammad Ahmad Imran, MBBS

    Shaikh Zayed Hospital, Lahore

    Principal Investigator
  • Muhammad Ashraf, DVM, PhD

    University Of Veterinary & Animal Sciences, Lahore

    Study Chair
  • Shoaib Ashraf, PhD

    Massachusetts General Hospital, Harvard Medical School, USA

    Study Director
  • Sohaib Ashraf, MBBS

    Federal Post-Graduate Medical Institute, Lahore

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Pakistan
  • Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital

    Lahore, Punjab Province, Pakistan

  • Services Institute of Medical Sciences, Services Hospital

    Lahore, Punjab Province, Pakistan

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2020
Primary completion
30 Aug 2020
Completion
30 Aug 2020
Last update posted
12 Nov 2020
Registered enrollment
313
Registry id
NCT04347382

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.